Adragos Pharma acquires Clinigen’s development unit, Lamda Laboratories
- Acquisition strengthens Adragos end-to-end integrated service offering within the pharmaceutical product development segment
- Agreement includes further product development activities for Clinigen Limited
- Lamda spurs further growth for Adragos as its 3rd site in Europe, and 5th globally
(Munich / London / Athens) – Munich-based pharmaceutical contract development organization (CDMO) Adragos Pharma GmbH has signed a definitive agreement with global pharmaceutical services company Clinigen Limitedto acquire Lamda Laboratories S.A. in Athens. The acquisition of Lamda Laboratories significantly expands Adragos' pharmaceutical product development, regulatory affairs and supply chain management services for its global pharmaceutical customers.
Lamda has not only acted as Clinigen’s sole development center but has also established a well-earned reputation as a highly reliable contract development organization (CDO) for third party customers. Under a pharmaceutical development services agreement, Lamda will continue to provide services for Clinigen Limited.
The Athens site, a mere 15 minute drive from the airport, is fully equipped with state of the art equipment including the handling of potent drugs, established Quality systems and a proven track record of delivering complex developments on time for customers.
A highly experienced management team and well-trained staff will continue to focus on complex product development for growing markets in Europe, Japan, and North America. Lamda will offer an expanded range of pharmaceutical development, regulatory affairs and supply chain management services for a wide range of dosage forms including complex and high potent oral solids, differentiated oral liquids, injectables and topical medicines. As part of the transaction, Adragos secures royalty streams for products stemming from previous co-developments.
David Bryant, Interim CEO of Clinigen Limited states: "We are pleased to have found in Adragos Pharma a trusted partner to build on the success story of Lamda with its great team taking it to the next level while also continuing to support Clinigen as we focus on providing high-value services to the biopharma industry.”
Dr. Andreas Raabe, CEO of Adragos Pharma commended the “impressive track record and professional service mindset at Lamda”. He noted that “Lamda combines differentiated product development capabilities with substantial scale, an essential combination for our international group.”
The exact terms of the transaction will not be disclosed. Completion of the transaction is subject to customary conditions precedent.
Adragos Pharma is a globally operating CDMO with headquarters in Munich, Germany. Its declared goal is to expand its existing production network through acquisitions in Europe, North America, and Japan to attain a globally leading position within the next few years and set new standards in customer service and data centricity. In its buy-and-build growth strategy, Adragos Pharma is supported by FSN Capital, a leading Northern European private equity firm, and Prange Group, a diversified leading German family office. Adragos Pharma currently operates four production sites in France, Germany, and Japan.www.adragos-pharma.com
Clinigen is a global, specialist pharmaceutical services company focused on providing ethical access to medicines. Its mission is to deliver the right medicine to the right patient at the right time. The Group supports pharmaceutical and biotech companies across the medical product lifecycle, from clinical through to commercial and operates from sites in North America, Europe, Africa and the Asia Pacific. Clinigen has more than 1,000 employees across five continents in 15 countries, and provides access in more than 120 countries every year. For more information on Clinigen, please visit: www.clinigengroup.com
Press contact Adragos Pharmapress@adragos-pharma.com
About news aktuell GmbH
+49 (0)40 4113-32589http://www.newsaktuell.de
news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
PMG Presse-Monitor strengthens management team: Welcomes Michelle Harold as new VP Global Sales5.6.2023 09:05:51 CEST | Press release
(Berlin, Germany) – PMG Presse-Monitor has expanded its management team welcoming Michelle Harold as Vice President Global Sales to lead PMG's international sales team from 5 June. With her extensive experience in the digital transformation of content, Michelle will lead PMG's market expansion emanating from their ongoing investment and commitment to innovation in the conversion and provision of high-quality digital publishing content. Michelle joins PMG having most recently serving as VP Global Sales at Ninestars Information Technologies. In welcoming Michelle to PMG, Managing Director Ingo Kästner, said: "I am delighted that Michelle, a proven expert in digital content transformation and strategic sales has joined our team. Her proven success impressively demonstrates her in-depth industry knowledge which alongside her commitment to excellence in customer service makes her the perfect choice for us! We are proud to have Michelle join the PMG leadership team and look forward to workin
AEHRA'S NEW SEDAN, A MADE-IN-ITALY MANIFESTO OF ELEGANCE AND INNOVATION, SET TO CHALLENGE THE ESTABLISHED ORDER2.6.2023 10:00:00 CEST | Press release
AEHRA, the Italian premium electric car brand, will unveil its new sedan on 16th June at the Monza racetrack in Italy
Press release of the German Publishers and Booksellers Association: Ewald Frie receives the German Non-Fiction Prize 2023 for his work “Ein Hof und elf Geschwister”2.6.2023 09:36:18 CEST | Press release
The winner of the German Non-Fiction Prize 2023 is Ewald Frie for his book “Ein Hof und elf Geschwister. Der stille Abschied vom bäuerlichen Leben in Deutschland” (“A Farm and Eleven Siblings. The Quiet Farewell to Rural Life in Germany”) (Publishers C.H.Beck).
MFM Ltd: A statement from Roger Waters on the controversy over his Berlin Concert30.5.2023 08:44:11 CEST | Press release
Frankfurt. “My recent performance in Berlin has attracted bad faith attacks from those who want to smear and silence me because they disagree with my political views and moral principles.
STIHL cuts carbon emissions and publishes 2022 Sustainability Report25.5.2023 13:56:44 CEST | Press release
In 2022, STIHL cut its direct carbon emissions (Scope 1 and 2) by a substantial margin compared to the prior year.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom